Virginia Bio works year round to
maintain its relationship with executive and legislative leaders in Virginia as
the source of information and public policy opinions on matters of bioscience
in the Commonwealth. Our efforts are
greatly leveraged through the efforts of our retained lobbyist, Myles Louria,
of Hunton & Williams.
At the state level, Virginia Bio works for policies that:
Over the years, Virginia Bio has led the development of a Bioscience Caucus in the General Assembly, and has had a significant hand in proposing and seeing through the passage of many of the incentives which are law today, including the Angel Investor Tax Credit, the Research and Development Tax Credit, and the Capital Gains exclusion for early investors in technology companies. These and other such policies appear Virginia Bioscience Incentives page.
Every year during the Legislative Session, Virginia Bio holds a statewide legislative reception in Richmond for Virginia Bio members and members of the General Assembly, and we organize small group dinners with legislators where supporting members can answer questions and make their viewpoints known. We encourage members to be in touch with their elected representatives, to make known the positions of Virginia Bio and their individual positions and concerns as well.
About the Virginia General Assembly:
The Virginia General Assembly dates from the establishment of the House of Burgesses at Jamestown in 1619. It is heralded by Virginians as the "oldest continuous law-making body in the New World.” The 1776 Virginia Constitution confirmed our bicameral legislature, which consists of the House of Delegates and Senate of Virginia. The present state Constitution, adopted in 1970, provides that the House of Delegates shall consist of 90 to 100 members and the Senate shall consist of 33 to 40 members. All members of the General Assembly are elected by qualified voters within their respective House and Senate districts. The terms of office are two years for members of the House and four years for members of the Senate. Members may not hold any other public office during their term of office. The General Assembly’s chief responsibilities are to represent citizens in the formulation of public policy, enact laws of the Commonwealth, approve the budget, levy taxes, elect judges and confirm appointments by the Governor.
Virginia Bioscience Legislative Caucus:
Virginia is one of approximately a dozen states with a "Biotech Caucus” in the state legislature. The Virginia Bioscience Legislative Caucus (VBLC) is a bi-partisan, bi-cameral group of approximately60 state legislators who share a common interest in the development of the bioscience industry in the Commonwealth of Virginia. The caucus is co-chaired by Delegate John O’Bannon and Senator Janet Howell. Please click here for a current list of caucus members.
Virginia General Assembly Information:
Each year during the General Assembly the Virginia Biotechnology Association tracks bills and resolutions introduced in the state legislature. During the General Assembly, click here to view links to the top legislation we are tracking for our members.
Who are my legislators?
Click here to find out who represents you in the state legislature.
Contact your legislator:
Working together to articulate a common message.
We work closely with national organizations of other state associations like VirginiaBio (the Council of State Bioscience Associations, and the Council of State Government Relations to identify issues before they arise, to find best practices, and to provide state policy makers the comparative information they require to determine how best for Virginia to compete and excel. We work with ally groups across the state, such as local and regional tech councils, to champion issues of common interest that are important to promoting entrepreneurship, innovation and investment in the Commonwealth.
Highlights of Virginia Bio Public Policy Accomplishments in recent years
2013: General Assembly Approves Increased Funding for Angel Investor Tax Credit
2012: $47 Million for Technology Initiatives in Governor’s Proposed Budget
2011: Virginia General Assembly Approves $15M in R&D Initiatives
Virginia Refundable R&D Credit Passes State Legislature
R&D Credit Top Legislative Priority for VA Bioscience Industry
2010: VABIO Agenda Passes 2010 State Legislature
Virginia State Senator Mark Herring Wins BIO’s National State Legislator of the Year Award
Virginia Biotechs Win $45 Million in Federal Awards
2009: VABIO Advocacy for "Founders’ Credit
VaBIO Victory at Legislature Delivers Bioscience Tax Credit